Status:
RECRUITING
Cervical Cancer Screening with NGS-HPV Technology Based on Menstrual Blood
Lead Sponsor:
Zhongnan Hospital
Collaborating Sponsors:
Wuhan Central Hospital
Huanggang Maternal and Child Health Hospital
Conditions:
Cervical Cancer
Eligibility:
FEMALE
20-60 years
Brief Summary
Our study is a population-based, cross-sectional study. This study is conducted to recruit cervical cancer screening participants to evaluate the application value of using high-throughput sequencing ...
Detailed Description
Our study will recruit 10,000 participants for cervical cancer screening across seven sites in Hubei Province from September 1, 2023, to March 31, 2028. The participating sites include: Fruit Lake Com...
Eligibility Criteria
Inclusion
- plan to undergo cervical screening
- with regular menstruation (21-35 days)
- agree to participate in this study and have signed an informed consent form
Exclusion
- with amenorrhea or menopause
- suffering from genital tract infection
- refuse to participate in this study
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2028
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT06082765
Start Date
September 1 2021
End Date
March 31 2028
Last Update
February 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Gynecologic Oncology
Wuhan, Hubei, China, 430062